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The study of the collision-induced dissociation behavior of various substituted isoquinoline-
3-carboxamides, which are amongst a group of drug candidates for the treatment of anemic
disorders (e.g., FG-2216), allowed for the formulation of the general mechanisms underlying
the unusual fragmentation behavior of this class of compounds. Characterization was achieved
with high-resolution/high accuracy LTQ-Orbitrap tandem mass spectrometry of the proton-
ated precursor ions. Presented data were substantiated by the synthesis and analysis of
proposed gas-phase intermediate structures and stable isotope labeled analogues, as well
as by density functional theory calculations. Exemplary, CID of protonated N-[(1-chloro-
4-hydroxy-7-isopropoxy-isoquinolin-3-yl)carbonyl]glycine gives rise to the isoquinoline-3-
carboxy-methyleneamide product ion which nominally eliminates a fragment of 11 u. This was
attributed to the loss of methyleneamine (29 u) and a concomitant spontaneous and
reversible water addition (18 u) to the resulting acylium ion to yield the protonated
isoquinoline-3-carboxylic acid. The same water addition pattern is observed after loss of
propylene (42 u). A further nominal loss of 10 u is explained by the elimination of carbon
monoxide (28 u) followed by another water adduct formation (18 u) to yield the protonated
1-chloro-3,4,7-trihydroxy-isoquinoline. The source of the multiple gas-phase water addition
remained unclear. This atypical fragmentation pattern proved to be highly characteristic for all
studied and differentially substituted isoquinoline-3-carboxamides, and offers powerful analytical
tools for the establishment of a LC/MS(/MS) based screening procedure for model HIF-stabilizers
and their potential metabolites in clinical, forensic and sports drug testing. (J Am Soc Mass
Spectrom 2009, 20, 2034–2048) © 2009 American Society for Mass SpectrometryThe transcriptional activator HIF (hypoxia-induciblefactor) is a central mediator in the concert ofcellular responses to deficient oxygen supply in
aerobic organisms [1] and its regulation has become an
important pivot point for the pharmacological treat-
ment of anemic diseases such as chronic kidney disease
(CKD) [2]. In normoxia, post-translational hydroxyla-
tion of two distinct proline residues in the oxygen-
dependent degradation domain of HIF induces its
rapid proteasomal degradation. Under hypoxic condi-
tions, the proline modification is suppressed, conse-
quently leading to HIF-stabilization and transcription
of genes for hypoxia compensating processes, such as
angiogenesis, erythropoiesis, and glucose metabolism
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doi:10.1016/j.jasms.2009.07.016[3]. Members of a conserved family of 2-oxoglutarate
and iron dependent enzymes, the prolyl hydroxylase
domain proteins (PHD), specifically catalyze the hy-
droxylation of HIF-prolyl residues in an oxygen depen-
dent manner, thus playing the pivotal role in molecular
oxygen sensing [4–6]. Various substances with the
capacity to inhibit PHD activity (prolyl hydroxylase
inhibitors, PHI) have been identified and analyzed
concerning their ability to induce the erythropoietic
cascade by HIF-stabilization [7, 8]; in this context,
substituted isoquinoline-3-carboxamides belong to the
most promising class of compounds regarding potential
clinical applications [9, 10]. The lead drug candidate
FG-2216 (Fibrogen and Astellas) is an orally available
anti-anemia agent that was shown to significantly raise
blood hemoglobin (Hb) levels in CKD patients in recent
phase II clinical trials [11, 12]. Remarkably, for the low
dosage cohort a significant Hb-rise was observed de-
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(Epo) levels, indicating the stimulation of the complete
erythropoietic machinery, including increased expres-
sion of genes for red blood cell maturation and en-
hanced iron metabolism (e.g., Epo receptor, transferrin
and its receptor, ferroprotein, and the divalent metal
transporter 1) [13]. After one case of death by fulminant
hepatitis caused a clinical hold of the phase II trial of
FG-2216, the FDA permitted to resume the clinical
testing in April 2008 [14, 15].
Since this novel compound class is capable of en-
hancing the organism’s capacity for molecular oxygen
transport, it also possesses great potential for abuse as
performance enhancing agent in sports. In the course of
preventive doping research, it is vital to timely identify
and characterize such substances, even before they
enter the open market as approved drug. In recent mass
spectrometric studies of a model PHI with isoquinoline-
3-carboxamide core, first fundamental data for the
development of analytical methods for HIF-stabilizing
potential drugs were presented [10]. An unusual disso-
ciation behavior was discovered that included a nomi-
nal loss of 11 u and the association of neutral molecules to
gas-phase ions. Such clustering reactions have been ob-
served earlier in several mass spectrometric studies [16–
18]. In particular, acylium fragment ions were shown to
readily undergo specific gas-phase ion-molecule reactions
[19], or associate with solvent molecules such as water to
complicate the interpretation of resulting product ion
mass spectra [20]. To further elucidate the phenomena
occurring during mass spectrometric fragmentation of
isoquinoline-3-carboxamides, we studied the collision in-
duced dissociation (CID) behavior of structurally related
model HIF-stabilizers build on the same isoquinoline
scaffold. The results from electrospray ionization high-
resolution/high accuracy ion trap/Orbitrap mass spec-
trometry were augmented by the synthesis and analysis
of stable isotope labeled analogues and proposed gas-
phase intermediate structures. Moreover they were
substantiated by density functional theory calculations,
yielding proton affinities and reaction energies of a
postulated fragmentation pathway. We propose a general
dissociation mechanism for isoquinoline-3-carboxamides,
explaining unusual nominal losses of 10 and 11 u by
reversible water adduct formation of gas-phase fragment
ions at numerous stages.
The dissociation behavior is shown to be highly
characteristic for isoquinoline-3-carboxamides and con-
stitutes a fundament upon which powerful analytical
tools for the screening for orally available HIF-stabiliz-
ers and their metabolites may be developed for clinical,
forensic, and sports drug testing.
Experimental
Chemicals and Reagents
Ethanol,methanol, ethyl acetate, petroleum ether, n-heptane,
diethyl ether, silica gel 60 (70–230 mesh), hydrochloric acid(36% aqueous solution, wt/wt), sulfuric acid (98%, wt/wt)
(all analytical grade), and ethanolamine (synthesis grade)
were purchased from Merck (Darmstadt, Germany),
dichloromethane, 1-butanol, Dowtherm A (eutectic mixture
of 26.5% of diphenyl and 73.5% of diphenyl oxide), N,N-
dimethylacetamide (all analytical grade), dimethylsulfoxide-
d6, acetone-d6, chloroform-d, methanol-d, deuterium oxide
(all 99.9 atom %), glycine-d5 (98 atom %), glycine (98%),
sodium, sodium hydroxide (99%), palladium (10% on active
charcoal), triethylamine (99%), N,N-diisopropylethylamine
(99%), benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium
hexafluorophosphate (98%), glycine methyl ester hy-
drochloride (99%, and [1-(chlorophenyl)-N-methyl-N-
(-1-methylpropyl)-3-isoquinoline carboxamide] were
obtained from Sigma (Deisendorf, Germany). 4-
Hydroxyphthalic acid (98%), 2-iodopropane (98%), po-
tassium carbonate (99%), potassium hydroxide (99%),
and phosphorous oxychloride (99%) were from Acros
(Geel, Belgium). Dihydrogen (technical grade 3.0) and
nitrogen gas (purity grade 5.0) were obtained from
Linde (Duesseldorf, Germany).
Synthesis of Model Compounds
Four model PHIs and related compounds were synthe-
sized in accordance to methods described elsewhere
[21]. Briefly, 4-hydroxyphthalic acid (Scheme 1a) was
converted into the diethylester and alkylated with 2-
iodopropane, to yield 4-(2-propyloxy)phthalic acid di-
ethyl ester, which liberated 4-(2-propyloxy)phthalic
acid (Scheme 1b) upon saponification. Reaction of b
with equimolar amount of glycine in Dowtherm at
200 °C gave rise to 4-(2-propyloxy)phthaloyl)iminoacetic
acid, which was esterified with 1-butanol and hydro-
chloric acid. The 5-membered heterocycle of the
resulting phthaloyliminoacetic acid 1-butyl ester
(Scheme 1c) was extended by treatment with 0.5 eq of
sodium butanolate at 95 °C to yield 4-hydroxy-7-(2-
propyloxy)-1(2H)-isoquinolone-3-carboxy-(1-butyl) es-
ter (Scheme 2, isomer d) and the 6-(2-propyloxy) isomer
e (Scheme 1) in a 1:2 ratio. The two isomers were
separated by fractionized crystallization, purified by
column chromatography (ethyl acetate on silica gel, Rf (d):
0.5; Rf(e): 0.35), and separately processed. Isomer d was
refluxed in phosphorous oxychloride to yield 1-chloro-4-
hydroxy-7-(2-propyloxy)isoquinoline-3-carboxy-(1-butyl)-
ester, which liberated the free carboxylic acid 5 (Figure 1,
Scheme 1) by alkaline hydrolysis. Amide bond formation
by reaction with glycine methyl ester hydrochloride and
benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium
hexafluorophosphate as coupling agent gave rise to the
isoquinoline-(3-carboxy)glycine amide methyl ester,
which was purified by flash chromatography using
ethyl acetate/n-heptane (1:3, vol/vol) on silica gel. Pure
target Compound 1 (Figure 1, Scheme 1) was obtained
by alkaline hydrolysis of the purified methyl ester.
te mo
2036 BEUCK ET AL. J Am Soc Mass Spectrom 2009, 20, 2034–2048Compound 2 (Figure 1, Scheme 1) was synthesized and
purified from Compound e in analogy to the synthesis
of 1. Moreover, dehalogenation of Compound 5 by
hydrogenation with palladium/active charcoal as cata-
lyst and subsequent glycine amide bond formation
allowed for the preparation of Compound 3 (Figure 1,
Scheme 1). Reaction of Compound f with ethanolamine
yielded Compound 4 (Figure 1, Scheme 1), which was
crystallized from ethyl acetate/n-heptane. An isotope
labeled analogue bearing two deuterium atoms in the
glycine residue (Compound 6, Figure 1, Scheme 1) was
synthesized by amide bond formation between d2-
labeled glycine methyl ester hydrochloride (Scheme
Scheme 1. Route of synthesis of drug candida1g) and Compound 5. All structures were confirmedby high field nuclear magnetic resonance spectros-
copy (NMR) with 1H (600 MHz), H,H-COSY, H,C-
HMQC, H,C-HMBC, and 13C APT (150 MHz) exper-
iments employing a Bruker AV 600 instrument
(Bruker, Karlsruhe, Germany) equipped with a 5 mm
inverse probe head (z-gradient coil). The spectra were
recorded at room temperature from solutions of 1, 2,
and 3 in dimethylsulfoxide-d6, 4 in chloroform-d, and
5 and 6 in acetone-d6, respectively (all 10 mg/mL),
and calibrated using the solvent residual peak as
reference signal. Additionally, the elemental compo-
sitions of the synthesized substances were deter-
mined using high-resolution/high accuracy mass
lecules and related compounds.spectrometry utilizing a LTQ Orbitrap (Thermo, Bre-
athw
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(FWHM).
Electrospray Ionization-Tandem
Mass Spectrometry
ESI-MS(/MS) experiments were conducted on a LTQ
Orbitrap mass spectrometer. Spectra were recorded in
positive ionization mode after calibration was achieved
with the manufacturer’s calibration mixture (containing
caffeine, MRFA, and Ultramark). Mass accuracies  5
ppm (calculated from 30 averaged spectra) were moni-
tored and accomplished for the period of analysis. Ana-
Scheme 2. Proposed dissociation plytes were dissolved in acetonitrile/water (1:1, vol/vol)containing 0.5% of formic acid at concentrations of 10
g/mL and introduced into the ion source of the mass
spectrometer with a syringe pump at a flow rate of 5
L/min. The ionization voltage was set to 4200 V, the
capillary temperature was 275 °C, and for MSn experi-
ments the precursor ions were isolated with a width of 1.5
Da. The protonated species were dissociated at normal-
ized collision energies between 12 and 30 arbitrary units
(Xcalibur software version 2.0; Thermo, Bremen, Ger-
many). Damping and collision gas in the linear ion trap
was helium (purity grade 5.0), while nitrogen, obtained
from a CMC nitrogen generator (CMC Instruments, Esch-
born, Germany), was used for the curved linear ion trap
ays of protonated drug candidate 1.(CLT). In addition to the Orbitrap experiments, ESI-MS(/
2038 BEUCK ET AL. J Am Soc Mass Spectrom 2009, 20, 2034–2048MS) studies were performed using anApplied Biosystems
API 2000 QTrap mass spectrometer (Darmstadt, Ger-
many) with electrospray ionization and direct infusion of
the analyte working solutions (vide supra) to examine
potential instrument-dependent differences in fragmenta-
tion pathways. Nitrogen was employed as curtain and
collision gas (5 103 Pa) delivered from a CMC nitrogen
generator (CMC Instruments, Eschborn, Germany), and
collision offset voltages or nozzle-skimmer dissociation
settings were optimized for each experiment.
Density Functional Theory Calculations
All molecular structures are fully optimized and are
obtained at the PBE [22]/def2-TZVP [23] level of theory as
well as the molecular and reaction energies are. The
resolution-of-identity (RI) approximation (also called den-
sity-fitting) for the two-electron Coulomb interactions has
been applied to speed up the calculations. The corre-
sponding optimized auxiliary basis sets [24] have been
taken from the TURBOMOLE libraries and a multiple
integration grid (m3) was used [25]. All computations
have been carried out with a locally modified version of
TURBOMOLE 5.9 [26–28]. Proton affinities are computed
as the differences between the total energies of the neutral
reactant and the cation without vibrational or thermal
contributions. Both are expected to play a minor role
especially when relative and not absolute proton affinities
are considered. They are also neglected for all other
relative energies.
Results and Discussion
Synthesis and Characterization of Model
PHI Compounds
The synthesis yielded the desired structures with over-
Figure 1. Molecular structures of studied comp
7-isopropoxy-isoquinolin-3-yl)carbonyl]glycine,
exemplary for all related structures; (2) N-[(1-chl
glycine; (3)N-[(4-hydroxy-7-isopropoxy-isoquin
isopropoxy-isoquinolin-3-carboxylic-acid-N-(2-h
diate structure 1-chloro-4-hydroxy-7-isopropoxy
beled drug candidate 1; (7) [1-(chlorophen
carboxamide] (PET-tracer PK11195).all yields ranging from 3% to 6% providing sufficientamounts of pure analytes for structure characterization
(purity estimated from 1H NMR: 95% to 98%). The
assignment of atomic numbers for NMR-characteriza-
tion is shown exemplary in Figure 1. Compound 1, 1H
NMR (DMSO-d6), : 13.59 (s, 1H, OH-4), 12.81 (s, broad,
1H), 9.09 (t, J  6.2 Hz, 1H, NH-12), 8.24 (d, J  9.0 Hz,
1H, CH-5), 7.58 (dd, J  9.0/2.3 Hz, 1H, CH-6), 7.50 (d,
J 2.3 Hz, 1H, CH-8), 4.92 (sept, J 6.1, 1H, CH-9), 4.02
(d, J  6.2 Hz, 2H, CH2-13), 1.38 (d, J  6.1 Hz, 6H,
CH3-10/10=); 13C NMR (DMSO-d6), : 170.77 (C-14), 169.13
(C-11), 159.85 (C-7), 154.58 (C-4), 137.16 (C-1), 130.84 (C-8a),
125.43 (C-5), 123.82 (C-6), 123.81 (C-4a), 119.24 (C-3), 107.01
(C-8), 70.68 (C-9), 40.90 (C-13), 21.68 (C-10/10=).
Compound 2, 1H NMR (DMSO-d6), : 13.59 (s, 1H,
OH-4), 12.85 (s, broad, 1H), 9.19 (t, J  6.2 Hz, 1H,
NH-12), 8.21 (d, J  9.1 Hz, 1H, CH-8), 7.59 (d, J  2.3
Hz, 1H, CH-5), 7.56 (dd, J  9.1/2.3 Hz, 1H, CH-7), 4.95
(sept, J  6.0, 1H, CH-9), 4.07 (d, J  6.2 Hz, 2H,
CH2-13), 1.41 (d, J  6.0 Hz, 6H, CH3-10/10=); 13C NMR
(DMSO-d6), : 170.71 (C-14), 166.13 (C-11), 159.89 (C-6),
153.59 (C-4), 138.56 (C-1), 131.74 (C4a), 128.58 (C-8), 124.04
(C-7), 123.67 (C-8a), 120.78 (C-3), 103.36 (C-5), 70.65 (C-9),
40.94 (C-13), 21.69 (C-10/10=), 21.59 (C-10/10=).
Compound 3, 1HNMR (DMSO-d6), : 13.54 (s, 1H,OH-4),
12.81 (s, broad, 1H), 9.27 (t, J  6.2 Hz, 1H, NH-12), 8.78
(s, 1H, CH-1), 8.20 (d, J 9.1 Hz, 1H, CH-5), 7.65 (d, J
2.3 Hz, 1H, CH-8), 7.47 (dd, J  9.1/2.3 Hz, 1H, CH-6),
4.90 (sept, J  6.0, 1H, CH-9), 4.06 (d, J  6.2 Hz, 2H,
CH2-13), 1.44 (d, J  6.0 Hz, 6H, CH3-10/10=); 13C NMR
(DMSO-d6), : 170.91 (C-14), 170.31 (C-11), 158.73 (C-7),
154.43 (C-4), 141.30 (C-1), 133.47 (C-8a), 124.10 (C-5), 123.38
(C-6), 121.70 (C-4a), 120.51 (C-3), 108.04 (C-8), 70.14 (C-9),
40.79 (C-13), 21.82 (C-10/10=).
Compound 4, 1H NMR (CDCl3), : 12.98 (s, 1H), 8.17
(broad m, 1H, NH-12), 8.10 (d, J  9.1 Hz, 1H, CH-8),
7.56 (d, J  2.5 Hz, 1H, CH-5), 7.31 (dd, J  9.1/2.5 Hz,
ds: drug candidates (1) N-[(1-chloro-4-hydroxy-
numbers for NMR characterization are shown
-hydroxy-6-isopropoxy-isoquinolin-3-yl)carbonyl]
-yl)carbonyl]glycine; (4) 1-chloro-4-hydroxy-6-
yethyl)amide; (5) putative gas-phase interme-
uinolin-3-carboxylic acid; (6) stable isotope la-
-methyl-N-(-1-methylpropyl)-3-isoquinolineoun
atom
oro-4
olin-3
ydrox
-isoq
yl)-N1H, CH-7), 4.81 (sept, J  6.0 Hz, 1H, CH-9), 3.90 (t, J 
2039J Am Soc Mass Spectrom 2009, 20, 2034–2048 ESI-CID OF ISOQUINOLINES5.2 Hz, 2H, CH2-14), 3.68 (m, 2H, CH2-13), 1.44 (d, J 
6.0 Hz, 6H, CH3-10/10=); 13C NMR (CDCl3), : 169.84
(C-11), 159.95 (C-6), 153.85 (C-4), 139.21 (C-1), 132.20
(C-4a), 128.36 (C-8), 123.96 (C-7), 123.76 (C-8a), 120.64
(C-3), 103.09 (C-5), 70.64 (C-9), 62.18 (C-14), 42.10 (C-13),
231.70 (C-10/10=).
Compound 5, 1H NMR (acetone-d6), : 8.34 (d, J 9.0
Hz, 1H, H-5), 7.60 (d, J  2.5 Hz, 1H, H-8), 7.59 (dd, J 
9.0/2.5 Hz, 1H, H-6), 4.99 (sept, J  6.0 Hz, 1H, H-9),
1.45 (d, J  6.0 Hz, 6H, H-10/10=); 13C NMR (acetone-
d6), : 171.25 (C-13), 161.23 (C-7), 156.57 (C-4), 138.37
(C-1), 132.35 (C-8a/C-4a), 125.95 (C- 5), 124.14 (C-6),
123.86 (C-8a/C-4a), 117.86 (C-3), 107.36 (C-8), 71.16
(C-9), 21.38 (C-10/10=).
Compound 6, 1H NMR (acetone-d6), : 8.30 (d, J 9.0
Hz, 1H, CH-5), 7.58 (d, J  2.4 Hz, 1H, CH-8), 7.54 (dd,
J 9.0/2.4 Hz, 1H, CH-6), 4.96 (sept, J 6.1, 1H, CH-9),
1.44 (d, J 6.1 Hz, 6H, CH3-10/10=); 13C NMR (acetone-
d6), : 170.34 (C-14), 169.51 (C-11), 160.58 (C-7), 154.95
(C-4), 137.75 (C-1), 131.63 (C-8a), 125.51 (C-5), 124.68
(C-6), 124.02 (C-4a), 119.71 (C-3), 107.36 (C-8), 70.91
(C-9), 29.42 (m, C-13), 21.44 (C-10/10=).
Electrospray Ionization-Tandem
Mass Spectrometry
Compound 1. To identify the protonation site, which is
important for the discussion of the dissociation path-
way, density functional theory calculations of proton
affinities at isoquinoline nitrogen (Figure 1, N-2) and
amide oxygen (CO-11) were conducted. Assuming a
conformationally rigid glycine amide residue that al-
lows for several stabilizing hydrogen bonds to be
formed, almost isoenergetic affinities at both positions
indicate that protonation can principally occur at both
sites (data not shown). However, in an excited-state, the
CO2-function is unlikely to be fixed in one conformation
as rotation around the bonds C13–C14 and N12–C13
can occur. In the case of a conformationally flexible
side-chain, protonation at N-2 was found to be energet-
ically favored.
Collisional activation of N-protonated N-[(1-Chloro-4-
hydroxy-7-isopropoxy-isoquinolin-3-yl)carbonyl]glycine
results in consecutive losses of water (18 u) and carbon
monoxide (28 u) giving rise to the product ions at m/z
321 and 293, respectively (Figure 2a, Table 1, Com-
pound 1). Besides the losses of water and carbon
monoxide, the precursor ion [M  H] generates a
fragment ion at m/z 238 by the elimination of C3H3NO3
(101 u). As verified by means of MS3 and MS4
experiments, the abundant ion at m/z 282 was shown to
originate from the precursor at m/z 293, corresponding
to a mass shift of11 u, and, according to the elemental
composition of the product ions, to a nominal loss of
HCN, concerted with the addition of an oxygen atom.
Simultaneously, the fragment ion at m/z 293 eliminates
CH2NH (29 u) to yield the product ion at m/z 264,
which, upon isolation and storage in the linear ion trap,spontaneously adds a water molecule (18 u) to create
the same product ion at m/z 282. Ultimately, MS3
experiments with m/z 293 as precursor ion generate a
product ion at m/z 251 by elimination of C3H6 (42 u).
This ion, only observed under MSn (n  2) conditions,
shows a similar dissociation pattern as its precursor at
m/z 293 with nominal losses of 11 u and 29 u yielding
the product ions at m/z 240 and 222, respectively (MS4,
Table 1). Again, the same product ions are obtained by
excitation of the ion at m/z 264 through elimination of
C3H6 (42 u,m/z 222) and subsequent addition of water
(18 u, m/z 240). MS4 experiments proved that the
product ion at m/z 222 gives rise to the fragment ions at
m/z 194 and 166 by consecutive losses of two molecules
of carbon monoxide (28 u,28 u), as well as to the ion
at m/z 212, corresponding to a nominal loss of 10 u
(“C”/“2H”). Similar to the ions at m/z 264 and 222,
the product ion at m/z 194, upon storage in the ion trap,
adds a water molecule (18 u) to yield the ion at m/z
212 with the same elemental composition as the one
mentioned above (Table 1).
This unusual dissociation pathway is in accordance
with the previously reported mass spectrometric behav-
ior of structurally related isoquinoline-3-carboxamides
also including a nominal loss of 11 u [10]. This was
attributed to the elimination of HCN (27 u) forming a
reactive carbene intermediate which was suggested to
rapidly add an oxygen atom (16 u). Due to the mass
spectrometric data on isoquinoline-3-carboxamide 1 re-
vealing a more complex fragmentation pathway as well
as another observed unusual nominal loss of 10 u,
additional experiments were conducted to elucidate the
dissociation mechanism causing these atypical findings.
As described above, the ion at m/z 282 is formally
generated from m/z 293 by elimination of HCN con-
certed with the addition of oxygen. Alternatively, this
ion can be formed by elimination of methyleneamine
(29 u) from the m/z 293 precursor to form a putative
acylium ion intermediate atm/z 264 which subsequently
associates a water molecule (18 u) to yield the ion at
m/z 282. DFT calculation of the reaction energies of the
two different dissociation pathways revealed the acy-
lium ion route including water adduct formation in the
gas-phase to be thermodynamically privileged by 16
kcal/mol as compared to the previously supposed
route via a reactive carbene intermediate.
To unequivocally identify the definite dissociation
pathway, an isotope labeled analogue of 1 bearing two
deuterium atoms at C-13 was synthesized and analyzed
(Compound 6, Figure 1 and 2b, Table 1). The doubly
deuterated and protonated precursor at m/z 341 consec-
utively eliminates water (18 u) and carbon monoxide
(28 u) to yield the product ion at m/z 295 still includ-
ing both deuterium atoms. In case of the suggested
carbene pathway, DCN elimination (– 28 u) and subse-
quent oxygen addition (16 u) in the MS3 spectrum of
the ion at m/z 295 should reveal the formation of a
singly deuterated product ion at m/z 283 (12 u).
Instead, both deuterium labels are eliminated from the
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spectrum of the unlabelled Compound 1 are observed
(m/z 282, 264, 240, and 222, Table 1, Compound 6).
Isolation of the ion at m/z 264, generated by MS2 or MS3
fragmentation of the precursors at m/z 341 or 295,
respectively, also yields the same water adduct at m/z
282 as Compound 1 (Table 1, 6). Together, these find-
ings clearly exclude the dissociation mechanism via the
reactive carbene intermediate in favor of the methylene-
Figure 2. ESI product ion spectra (LTQ-Orbitr
(CE)  25 arbitrary units (au), MS3 experiment
arbitrary units, MS3 experiment CE  18 au; (c)
MS4 experiment CE  15 au.amine elimination pathway via the acylium ion at m/z264, which subsequently associates a water molecule to
yield the ion at m/z 282.
Moreover, the intermediate fragment ion of the deu-
terated precursor at m/z 295 generates a product ion at
m/z 253 (42 u, Table 1, Compound 6) which, upon MS4
excitation, yields the ions at m/z 240 and 222 (13 u,
31 u, respectively). These ions undergo the same
water addition pattern as observed for m/z 264 and 282.
Finally, the protonated molecule of Compound 6 at m/z
f protonated (a) Compound 1, collision energy
19 au; (b) Compound 6, collision energy  25
pound 5, collision energy  25 arbitrary units,ap) o
CE 
Com341 eliminates C3HD2NO3 (103 u) to produce the ion
Table 1. Elemental compositions of protonated precursors and product ions of Compound 1 and analogues in high resolution/high accuracy MS experiments
Compound
Precursor ion (m/z)
Elemental comp.
Error
(ppm)
Collision energy
(arb. units)
Product
ion (m/z) Elemental comp.
Error
(ppm) Cleaved speciesMS2 MS3 MS4
1 339.0754 3.4 25 C15H16O5N2Cl 321.0647 C15H14O4N2Cl 3.1 H2O
293.0697 C14H14O3N2Cl 3.3 H2O, CO
282.0540 C13H13O4NCl 4.3 H2O, CO, CH2NH, H2O
264.0431 C13H11O3NCl 3.6 H2O, CO, CH2NH
240.0065 C10H7O4NCl 3.0 H2O, CO, CH2NH, C3H6, H2O
238.0636 C12H13O2NCl 2.9 C3H3NO3
221.9959 C10H5O3NCl 3.1 H2O, CO, CH2NH, C3H6
321.0644 C15H14O4N2Cl 2.4 12 293.0694 C14H14O3N2Cl 2.1 CO
293.0694 C14H14O3N2Cl 2.4 19 282.0534 C13H13O4NCl 2.2 CH2NH, H2O
264.0428 C13H11O3NCl 2.3 CH2NH
251.0224 C11H8O3N2Cl 2.3 C3H6
240.0064 C10H7O4NCl 2.4 CH2NH, C3H6, H2O
221.9958 C10H5O3NCl 2.3 CH2NH, C3H6
251.0222 C11H8O3N2Cl 1.7 20 240.0062 C10H7O4NCl 1.6 CH2NH, H2O
221.9956 C10H5O3NCl 1.7 CH2NH
264.0428 C13H11O3NCl 2.2 20 282.0534 C13H13O4NCl 2.1 H2O
240.0063 C10H7O4NCl 2.1 C3H6, H2O
221.9958 C10H5O3NCl 2.5 C3H6
212.0113 C9H7O3NCl 2.1 C3H6, CO, H2O
194.0007 C9H5O2NCl 1.7 C3H6, CO
221.9957 C10H5O3NCl 2.2 20 240.0063 C10H7O4NCl 2.1 H2O
212.0114 C9H7O3NCl 2.2 CO,  H2O
194.0006 C9H5O2NCl 1.6 CO
166.0057 C8H5ONCl 1.5 CO, CO
193.9997 C9H5O2NCl 3.1 13 212.0103 C9H7O3NCl 2.7 H2O
166.0048 C8H5ONCl 3.5 CO
238.0621 C12H13O2NCl 3.5 18 196.0153 C9H7O2NCl 3.4 C3H6
6 341.0866 C15H14D2O5N2Cl 0.4 25 323.0761 C15H12D2O4N2Cl 0.3 H2O
295.0812 C14H12D2O3N2Cl 0.5 H2O, CO
282.0528 C13H13O4NCl 0.1 H2O, CO, CD2NH, H2O
264.0421 C13H11O3NCl 0.2 H2O, CO, CD2NH
240.0059 C10H7O4NCl 0.7 H2O, CO, CD2NH, C3H6, H2O
238.0628 C12H13O2NCl 0.6 C3D2HNO3
221.9951 C10H5O3NCl 0.5 H2O, CO, CD2NH, C3H6
295.0809 C14H12D2O3N2Cl 1.4 18 282.0523 C13H13O4NCl 1.7 CD2NH,  H2O
264.0417 C13H11O3NCl 1.9 CD2NH
253.0339 C11H6D2O3N2Cl 1.7 C3H6
240.0053 C10H7O4NCl 2.1 CD2NH, C3H6, H2O
221.9949 C10H5O3NCl 1.7 CD2NH, C3H6
253.0338 C11H6D2O3N2Cl 2.1 18 240.0053 C10H7O4NCl 2.1 CD2NH, H2O
221.9948 C10H5O3NCl 1.8 CD2NH
1-d4 (
37Cl) 345.1026 C15H12D4O5N2Cl 18.0 20 325.0732 C15H12D2O4N2Cl 0.2 D2O
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2042 BEUCK ET AL. J Am Soc Mass Spectrom 2009, 20, 2034–2048at m/z 238 while all dissociations in the lower mass
region of the spectrum generate the same product ions
as in the case of the unlabelled Compound 1.
Exchange of mobile protons by deuterons and
subsequent ionization from D2O/methanol-d yields
the d4-analogue of Compound 1 (m/z 343). To exclude
interferences with the 37Cl isotope of the molecule
obtained from two H/D exchanges (also m/z 343), the
37Cl d4-isotope at m/z 345 was subjected to MS/MS
experiments (Table 1, Compound 1-d4 [
37Cl]). Evidence
was furnished for the loss of D2O (20 u) yielding the
product ion at m/z 325 which subsequently eliminates
CO (28 u) to generate the doubly deuteronated prod-
uct ion at m/z 297. In accordance with the mechanism
presumed above, this ion gives rise to the product ions
at m/z 267 (CHDNH, 30 u), 285 (CHDNH, 30 u; 
H2O, 18 u), and 255 (C3H6, 42 u) in MS
3 experiments
(Table 1).
Based on these data, dissociation pathways for the
protonated molecule 1 and a general mechanism for the
nominal losses of 10 and 11 u in the mass spectra of
isoquinoline-3-carboxamides are proposed. As shown in
Scheme 2, the protonated precursor of 1 (m/z 339) elimi-
nates water and carbon monoxide to yield the 1-chloro-
4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid
methyleneamide cation (pathway a). Hydrogen transfer
from the protonation site to the nitrogen atom of the
leaving group and subsequent elimination of methyl-
eneamine (b) generates the isoquinoline-3-acylium ion
at m/z 264, which reversibly (vide infra) adds a water
molecule to produce the isoquinoline-3-carboxylic acid
cation (c, m/z 282). Hence, the nominal loss of 11 u is
suggested to be actually composed of a methyleneam-
ine elimination (27 u) and an instantaneous water
addition (18 u) via an acylium ion intermediate.
As reported earlier, the water association in the gas
phase of the mass spectrometer appeared to be highly
reversible, allowing for MSn “ping-pong” experiments
(up to MS7 to be conducted in the linear ion trap, where
storage of the isoquinoline-3-acylium ion spontane-
ously produces the carboxylic acid as water adduct,
which, upon excitation, re-eliminates the water mole-
cule to restore the initial anhydride ion structure (data
not shown). The inability to fully decompose the ion at
m/z 282 even by application of high excitation energies
(up to 100 eV) further substantiates the high spontane-
ousness of the acylium ion-water association explaining
the favored gas-phase ion structure of the isoquinoline-
3-carboxylic acid.
The same reversible gas-phase water addition path-
way is observed between the 1-chloro-4,7-dihydroxy-
isoquinoline-3-acylium ion (m/z 222) and the corre-
sponding carboxylic acid (m/z 240, e) after propene
elimination (Scheme 2, pathway d). This set of fragment
ions can also be generated via an alternative route f, e.g.,
by initial propene elimination to yield the 1-chloro-4,7-
dihydroxy-isoquinoline-3-carboxylic acid methyleneamide
cation at m/z 251 and subsequent loss of methyleneam-
ine. Further evidence for the reversible gas-phase waterTa C
o
2043J Am Soc Mass Spectrom 2009, 20, 2034–2048 ESI-CID OF ISOQUINOLINESaddition pattern is furnished by another unusual nom-
inal loss of 10 u that can be explained by this
phenomenon: The acylium function of the product
ion at m/z 222 is eliminated as carbon monoxide to
yield the charge-delocalized 1-chloro-4,7-dihydroxy-
isoquinoline-carbenium ion (h), which, again reversibly,
re-associates water to yield a trihydroxyisoquinoline
cation, such as the protonated 1-chloro-3,4,7-dihydroxy-
isoquinoline (i).
In another fragmentation route, the precursor at m/z
339 yields a product ion at m/z 238, which is proposed
to be generated by nucleophilic attack of the carboxylic
oxygen at the amide carbon, concomitant hydrogen
transfer, and final elimination of C3H3NO3, such as ther-
modynamically stable 2,5-oxazolidinedione (route k).
The proposed gas-phase structures shown in Scheme
3 agree with the previously reported dissociation of
related isoquinoline-3-carboxamides [10]. They could
additionally be substantiated by the analysis of chem-
ically synthesized 1-chloro-4-hydroxy-7-isopropoxy-
isoquinoline-3-carboxylic acid (Compound 5, Figure 1,
Scheme 1) constituting the proposed gas-phase struc-
ture of the water adduct ion at m/z 282 which generates
the same product ions in offline ESI-MSn experiments as
the protonated molecule of Compound 1 (Figure 2c,
Table 1, 5).
Compounds 2–4. The CID behavior of protonated mol-
ecules of 2–4 basically follow the same pattern as
described in detail for Compound 1 above (Figure 3,
Table 2). In accordance to 1, the product ion spectrum of
the protonated 6-isopropoxy analogue (Figure 1, Com-
pound 2) reveals the same set of fragment ions and
characteristic ion transitions (nominal losses of 11 and
10 u, multiple reversible water addition to fragment
ions) with two additional signals at m/z 297 and 251
Scheme 3. (a) Possible charge delocalization in
of propene from resonance structure m/z 339b. (b
ion at m/z 264, therefore the immediate prope
favored. For the analogous product ion at m/z 26
resonance structure 264b can be formulated (not sho(Figure 3a, Table 2, 2) originating from the immediate
cleavage of the 6-isopropoxy function from the precur-
sor at m/z 339 (42 u; m/z 297) and subsequent losses of
water and carbon monoxide (18 u, 28 u; m/z 251),
respectively. Assuming a protonation at N-2, the fa-
vored propene elimination from the precursor at m/z
339 could be due to a possible delocalization of the
positive charge to the 6-isopropoxy oxygen, thus poten-
tially facilitating the dissociation of the isopropoxy-C–O
bond (Scheme 3a). For Compound 1, which is lacking
evidence for initial propene elimination, the corre-
sponding resonance structure cannot be formulated. In
fact, DFT calculations of the partial charge at iso-
propoxy-oxygen (natural bond order charge analysis)
for the N-protonated Compounds 1 and 2 proved the
oxygen in 2 to be less negatively charged (0.390 for 2;
0.398 for 1), indicating a higher contribution of reso-
nance structure 339b (Scheme 3a) to the actual electron
distribution of protonated 2.
Moreover, MS3 experiments with the acylium ion at
m/z 264 yield two additional fragment ions at m/z 254
(10 u) and 236 (28 u; Table 2, Compound 2), corre-
sponding to an elimination of carbon monoxide (m/z
236), concerted with the association of a water molecule
(m/z 254, Table 2). Interestingly, the nominal loss of 10 u
at this stage of the dissociation pathway is favored
because the propene elimination, which is readily ob-
served in case of Compound 1 yielding the product ion
at m/z 222, seems to be impeded for the 6-isopropoxy
isomer. In contrast to the precursor at m/z 339, initial
localization of the positive charge at the 3-acylium ion
function of the isoquinoline ring allows for the formu-
lation of a resonance structure with positively charged
isopropoxy-oxygen only if it is linked to the 7-position
of the heterocycle. This is believed to explain the
preferred propene elimination from the 7-isopropoxy-
nated Compound 2, facilitating the elimination
cordant delocalization is not possible in product
limination is hindered and CO elimination is
Compound 1, which only eliminates propene, aproto
) Ac
ne e
4 ofwn).
u.
2044 BEUCK ET AL. J Am Soc Mass Spectrom 2009, 20, 2034–2048isoquinoline-3-acylium ion (originating from 1) while
the 6-isopropoxy isomer 2 additionally generates the
isoquinoline carbenium ion at m/z 236 and the cation at
Figure 3. ESI product ion spectra (LTQ-Orbitr
(CE)  25 arbitrary units (au), MS3 experiment
arbitrary units, MS3 experiment CE  30 au; (c)
MS3 CE 15 au; (d) ESI product ion spectrum (Q
units, MS3 experiment excitation energy  18 am/z 254, such as the protonated 1-chloro-6-isopropoxy-3,4-dihydroxy isoquinoline, by subsequent water ad-
duct formation (Scheme 3b).
Protonated Compound 3 (m/z 305, Figure 1) dissoci-
f protonated (a) Compound 2, collision energy
18 au; (b) Compound 3, collision energy  25
pound 4, collision energy  23 arbitrary units,
) of Compound 7, collision energy 25 arbitraryap) o
CE 
Com
Trapates via the same routes as described above for Com-
Table 2. Elemental compositions of protonated precursors and product ions of Compounds 2–4 in high resolution/high accuracy MSn experiments
Compound
Precursor ion (m/z)
Elemental comp.
Error
(ppm)
Collision energy
(arb. units)
Product ion
(m/z) Elemental comp.
Error
(ppm) Cleaved speciesMS2 MS3 MS4
2 339.0753 C15H16O5N2Cl 3.1 25 321.0646 C15H14O4N2Cl 2.9 H2O
297.0280 C12H10O5N2Cl 2.4 C3H6
293.0698 C14H14O3N2Cl 3.6 H2O, CO
282.0538 C13H13O4NCl 3.7 H2O, CO, CH2NH, H2O
264.0430 C13H11O3NCl 3.0 H2O, CO, CH2NH
251.0225 C11H8O3N2Cl 2.9 H2O, CO, C3H6
240.0065 C10H7O4NCl 2.8 H2O, CO, CH2NH, C3H6, H2O
238.0636 C12H13O2NCl 2.8 C3H3O3N
221.9959 C10H5O3NCl 3.1 H2O, CO, CH2NH, C3H6
297.0281 C12H10O5N2Cl 2.7 16 279.0174 C12H8O4N2Cl 2.5 H2O
251.0223 C11H8O3N2Cl 2.1 H2O, CO
240.0063 C10H7O4NCl 2.2 H2O, CO, CH2NH, H2O
221.9957 C10H5O3NCl 2.3 H2O, CO, CH2NH
279.0172 C12H8O4N2Cl 1.9 251.0222 C11H8O3N2Cl 1.7 CO
282.0535 C13H13O4NCl 2.7 25 264.0429 C13H11O3NCl 2.8 H2O
240.0064 C10H7O4NCl 2.5 C3H6
221.9958 C10H5O3NCl 2.7 C3H6, H2O
264.0428 2.2 18 282.0534 C13H13O4NCl 2.2 H2O
254.0584 C12H13O3NCl 2.3 CO, H2O
240.0063 C10H7O4NCl 2.1 C3H6, H2O
236.0478 C12H11O2NCl 2.1 CO
221.9957 C10H5O3NCl 2.2 C3H6
212.0113 C9H7O3NCl 2.0 C3H6, CO, H2O
194.0006 C9H5O2NCl 1.6 C3H6, CO
166.0056 C8H5ONCl 1.3 C3H6, CO, CO
254.0572 C12H13O3NCl 2.6 16 212.0103 C9H7O3NCl 2.6 C3H6
3 325.0947 C15H18O4N2Cl 0.9 23 307.0841 C15H16O3N2Cl .0 H2O
283,0475 C12H12O4N2Cl 1,7 C3H6
282.0526 C13H13O4NCl 0.6 NH2C2H4OH, H2O
265.0372 C12H10O3N2Cl 0,9 H2O, C3H6
264.0419 C13H11O3NCl 0.9 NH2C2H4OH
240,0055 C10H7O4NCl 1,3 NH2C2H4OH, C3H6
307,0840 C15H16O3N2Cl 1,4 18 265,0370 C12H10O3N2Cl 1,8 C3H6
265,0370 C12H10O3N2Cl 1,8 20 240,0053 C10H7O4NCl 2,2 C2H3NH2, H2O
221,9948 C10H5O3NCl 1,8 C2H3NH2
283,0475 C12H12O4N2Cl 1,9 14 265,0368 C12H10O3N2Cl 2,3 H2O
240,0052 C10H7O4NCl 2,5 H2O, C3H6
282,0524 C13H13O4NCl 1,3 30 264,0419 C13H11O3NCl 1,2 H2O
240,0055 C10H7O4NCl 1,3 H2O, C3H6, H2O
221,9950 C10H5O3NCl 1,1 H2O, C3H6
264,0417 C13H11O3NCl 1,7 18 282,0523 C13H13O4NCl 1,6 H2O
254,0574 C12H13O3NCl 1,7 CO, H2O
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Table 2. Continued
Compound
Precursor ion (m/z)
Elemental comp.
Error
(ppm)
Collision energy
(arb. units)
Product ion
(m/z) Elemental comp.
Error
(ppm) Cleaved speciesMS2 MS3 MS4
240,0054 C10H7O4NCl 1,8 C3H6, H2O
236,0469 C12H11O2NCl 1,6 CO
221,9949 C10H5O3NCl 1,4 C3H6
212,0105 C9H7O3NCl 1,7 C3H6, CO, H2O
193,9999 C9H5O2NCl 2,9 C3H6, CO
166,0050 C8H5ONCl 2,3 C3H6, CO, CO
4 305.1142 C15H17O5N2 3.3 25 287.1035 C15H15O4N2 2.9 H2O
263.0669 C12H11O5N2 2.6 C3H6
259.1084 C14H15O3N2 2.5 H2O, CO
248.0926 C13H14O4N 3.4 H2O, CO, CH2NH, H2O
230.0820 C13H12O3N 3.8 H2O, CO, CH2NH
220.0975 C12H14O3N 3.1 H2O, CO, CH2NH, CO, H2O
217,0614 C11H9O3N2 3,1 C3H6, H2O, CO
206,0453 C10H8O4N 2,6 C3H6, H2O, CO, CH2NH, H2O
204.1025 C12H14O2N 2.7 C3H3O3N
188.0347 C10H6O3N 2.4 C3H6, H2O, CO, CH2NH
162.0553 C9H8O2N 2.2 C3H3O3N, C3H6
263.0669 C12H11O5N2 2.4 17 245.0562 C12H9O4N2 2.2 H2O
217.0613 C11H9O3N2 2.3 H2O, CO
206.0452 C10H8O4N 1.8 H2O, CO, CH2NH, H2O
188.0345 C10H6O3N 1.7 H2O, CO, CH2NH
259.1083 C14H15O3N2 2.1 21 248.0923 C13H14O4N 2.1 CH2NH, H2O
230.0817 C13H12O3N 2.1 CH2NH
217.0613 C11H9O3N2 2.3 C3H6
188.0346 C10H6O3N 1.8 CH2NH, C3H6
230.0818 C13H16O3N 2.6 30 248.0924 C13H14O4N 2.8 H2O
220.0974 C12H14O3N 2.7 CO, H2O
206.0453 C10H8O4N 2.4 C3H6, H2O
188.0347 C10H6O3N 2.5 C3H6
178.0503 C9H8O3N 2.3 C3H6, CO, H2O
160.0396 C9H6O2N 2.2 C3H6, CO
132.0477 C8H6ON 2.6 C3H6, CO, CO
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2047J Am Soc Mass Spectrom 2009, 20, 2034–2048 ESI-CID OF ISOQUINOLINESpounds 1 and 2 (Figure 3b, Table 2). However, as
the loss of 42 u (C3H6) is observed in all stages of
the fragmentation, the increase of electron density in
the aromatic isoquinoline ring system by chemical
removal of the electronegative chlorine atom seems to
compensate for the direction of propene elimination
(vide supra). Another effect of the change in electron
distribution might be the favored elimination of
2,5-oxazolidinedione (101 u) from the precursor at
m/z 305 to form the abundant ion at m/z 204 (Figure
3b), supposedly the protonated 4-hydroxy-7-
isopropoxy-isoquinoline.
CID of protonated Compound 4 (m/z 325, Figure 1)
finally substantiates the general validity of the postulated
fragmentation behavior of substituted 4-hydroxy-
isoquinoline-3-carboxamides: The same characteristic re-
versible water addition pattern giving rise to the favored
gas-phase ion structure of protonated isoquinoline-3-
carboxylic acids is observed (Figure 3c, Table 2) even
though the initial fragmentation route is modified by
substitution of a 2-ethanolamide residue for the N-
glycinamide function (Scheme 1). Besides the ion at m/z
307, originating from initial water elimination, the most
abundant ion at m/z 282 is generated by immediate loss
of ethanolamine from the precursor at m/z 325 to form
the isoquinoline-3-acylium ion at m/z 264 and subse-
quent spontaneous water addition. All fragment ions
resulting from m/z 264 coincide with the product ions of
protonated 2 (Table 2), ultimately corroborating the
postulated dissociation pathways and mechanisms.
The minimum prerequisite for the observed distinctive
fragmentation behavior of substituted isoquinolines
seems to be the isoquinoline-3-carboxamide core, whereas
the effects of substituents on the heterocycle and the kind
of amide bond residue, e.g., amino acetic acid, ethanol-
amine, amine, etc., are negligible. Evidence for this is
furnished by the mass spectrum of protonated PK11195
[1-(chlorophenyl)-N-methyl-N-(-1-methylpropyl)-3-
isoquinoline carboxamide] (Figure 1, Compound 7), a
widely used clinical tracer (11C-PK11195) for the visu-
alization of neuronal damage by positron emission
spectroscopy [29], which also comprises an isoquinoline-
3-carboxamide core and undergoes a similar char-
acteristic fragmentation, despite different substitution
pattern. To prove the phenomena to be independent
from the instrumental layout of the mass spectrometer,
an API 2000 QTrap instrument was used for this exper-
iment. CID of the protonated precursor at m/z 353 gives
rise to a mass spectrum (Figure 3d) including two
reversible water addition steps (m/z 266 284; m/z 238
256) and nominal losses of 13 u from the precursor ion
at m/z 297 and 10 u from m/z 266, respectively, in MS3
experiments. In fact, analysis of all presented com-
pounds on the API 2000 QTrap mass spectrometer in
positive ESI mode yielded the same product ions as
obtained with the LTQ-Orbitrap (data not shown), even
if in-space instead of in-time dissociation is applied.
Stunningly, the source of the gas-phase water re-
sponsible for the unusual observations remains unclear.The water molecule initially (and irreversibly) cleaved
from the precursor ions at 339 (1, 2), 305 (3), and 325 (4),
respectively, as well as the solvation/ionization process
could be ruled out as origin of the water addition by
H/D-exchange experiments (vide supra) and the use of
deuterium oxide as infusion solvent. Attempts to ex-
change potential residual water in the Orbitrap as well
as the QTrap mass spectrometer by direct infusion of
deuterium oxide/methanol-d at an average flow rate of
5 L/min for 72 h did not affect the masses of the
relevant fragment ions. Moreover, the nitrogen genera-
tor could be excluded as moisture source by applica-
tion of commercial dry nitrogen (purity grade 5.0) as
sheath and collision gas to the QTrap mass spectrom-
eter. The identification of the source of neutral reac-
tants within mass spectrometers was shown to be a
highly complex task also in earlier studies, which
reported on similar solvation phenomena with differ-
ent acylium fragment ions in quadrupole ion trap and
Fourier transform ion cyclotron resonance mass spec-
trometers [20]. In accordance with that, the origin as
well as the driving force for the described phenomena
yet remains to be clarified.
Conclusion
Mass spectrometric investigation of protonated
isoquinoline-3-carboxamides, a class of drug candi-
dates that are of urgent interest in preventive doping
research, yielded atypical dissociation pathways, in-
cluding multiple, reversible water association of acy-
lium fragment ions at several stages. This allowed for
the formulation of fragmentation mechanisms charac-
teristic for this compound class. Aiming at analytical
assay development with QTrap mass spectrometers,
neutral loss scans for 11 u could be utilized in screen-
ings for substituted (isoquinoline-3-carboxy)glycines,
whereas a neutral loss of 10 u is shown to serve as
potential diagnostic ion transition for compounds com-
prising an isoquinoline-3-carboxamide core. This en-
ables the detection of potential metabolites and a wide
variety of structural analogues that might emerge from
the ongoing clinical development of prolylhydroxylase
inhibitors as novel lead drug candidates.
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